Cyclic adenosine monophosphate inhibits quinolone alkaloid evocarpine-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells
Ny. Kim et al., Cyclic adenosine monophosphate inhibits quinolone alkaloid evocarpine-induced apoptosis via activation of protein kinase A in human leukaemic HL-60 cells, PHARM TOX, 87(1), 2000, pp. 1-5
Evocarpine, an isoquinolone alkaloid isolated from the fruit of Evodia ruta
ecarpa, was found to induce apoptotic cell death in promyelocytic leukaemia
HL-60 cells in dose- and time-dependent manners. We investigated the invol
vement of protein kinase A during the evocarpine-induced apoptotic cell dea
th. Evocarpine-induced apoptosis was markedly inhibited by treatment of the
cells with dibutyryl-cyclic adenosine monophosphate. Similar results were
obtained with other commonly used cyclic adenosine monophosphate analogues,
chlorophenylthio-cyclic adenosine monophosphate and the intracellular cycl
ic adenosine monophosphate-elevating agent, forskolin. In contrast, pretrea
tment of HL-60 cells with KT5720, an inhibitor of cyclic adenosine monophos
phate-dependent protein kinase A, abrogated the protective effects of cycli
c adenosine monophosphate analogues and forskolin on evocrpine-induced apop
tosis. These findings suggest that cyclic adenosine monophosphate-dependent
activation of protein kinase A plays a crucial role in protecting HL-60 ce
lls from the evocarpine-induced apoptotic cell death.